✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals

Titan Bio-Tech Ltd.

TITANBIO

Market Cap
₹412 Cr.
P/E
18.33

Titan Bio-Tech Ltd.

  • Titan Bio-Tech
  • Multibase India
  • Alufluoride
FAQs on Titan Bio-Tech Ltd. Shareprice

Titan Bio-Tech has given better returns compared to its competitors.
Titan Bio-Tech has grown at ~31.9% over the last 10yrs while peers have grown at a median rate of 17.52%

Yes, Titan Bio-Tech is expensive.
Latest PE of Titan Bio-Tech is 18.1, while 3 year average PE is 12.3.
Also latest EV/EBITDA of Titan Bio-Tech is 14.24 while 3yr average is 9.12.

View FAQ's On Business
Growth Table
  • Titan Bio-Tech Ltd.
  • Multibase India
  • Alufluoride
Balance Sheet
  • Titan Bio-Tech Ltd.
  • Multibase India
  • Alufluoride
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Titan Bio-Tech Ltd.
  • Multibase India
  • Alufluoride
Cash Flow
  • Titan Bio-Tech Ltd.
  • Multibase India
  • Alufluoride
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Titan Bio-Tech Ltd.
  • Multibase India
  • Alufluoride
Quarterly Results
  • Titan Bio-Tech Ltd.
  • Multibase India
  • Alufluoride
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Titan Bio-Tech Ltd. Financials

Balance sheet of Titan Bio-Tech is strong.
It shouldn't have solvency or liquidity issues.

The debt of Titan Bio-Tech is decreasing.
Latest debt of Titan Bio-Tech is -₹9.23 Crs as of Sep-24.
This is less than Mar-24 when it was ₹1.57 Crs.

The profit is oscillating.
The profit of Titan Bio-Tech is ₹19.35 Crs for TTM, ₹24.85 Crs for Mar 2024 and ₹24.84 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Titan Bio-Tech latest dividend payout ratio is 6.65% and 3yr average dividend payout ratio is 6.12%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech